<DOC>
	<DOC>NCT02590510</DOC>
	<brief_summary>The main purpose of this study is to compare the effect of 10 mg and 15 mg methotrexate in the treatment of meningeal carcinomatosis.</brief_summary>
	<brief_title>Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>age 14 or more a history of solid tumor a new clinical neurological signs and symptoms a typical CT(Computerized Tomography,CT) or MRI(Magnetic Resonance Imaging,MRI) imaging findings tumor cells in cerebrospinal fluid KPS score &lt;60 the tumor patients with organ failure bacteria, fungi or viral meningitis</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Intrathecal chemotherapy</keyword>
</DOC>